Rovi Pharmaceuticals Laboratories
Clinical trials sponsored by Rovi Pharmaceuticals Laboratories, explained in plain language.
Pharmaceutical company focused on injectable drugs and heparin products.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New injectable treatment shows promise for schizophrenia relapse
Disease control CompletedThis study looked at how well Risperidone ISM works for people with schizophrenia who were hospitalized after a relapse. Researchers tracked 275 patients over 56 days to see if their symptoms improved and if they could better manage daily life. The treatment is given as an inject…
Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 27, 2026 08:02 UTC
-
Schizophrenia treatment could go from daily pills to four shots a year
Disease control CompletedThis early-phase study tested a new long-acting injection of the antipsychotic drug risperidone that would only need to be given once every three months. Fifty-eight adults with stable schizophrenia received a single shot at different doses to measure how the drug moves through t…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Disease control
Last updated Jun 26, 2026 15:04 UTC
-
Healthy women test new Long-Acting hormone drug injection
Knowledge-focused CompletedThis early-stage study tests a single injection of a long-acting form of letrozole in 90 healthy post-menopausal women. The goal is to measure how the drug moves through the body and check for side effects. Participants receive one injection and are monitored closely. No direct h…
Phase: PHASE1 • Sponsor: Rovi Pharmaceuticals Laboratories • Aim: Knowledge-focused
Last updated Jul 26, 2026 00:00 UTC